Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 1a/1b, Multicenter, Open-label, Dose-escalation and Dose-expansion Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK112 in Subjects with Advanced Solid Tumors
Frentzas, Sophia
(Primary Chief Investigator (PCI))
Parakh, Sagun
(Primary Chief Investigator (PCI))
Frentzas, Sophia
(Primary Chief Investigator (PCI))
Body, Amy
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
15/11/19
→
14/11/24
View all
View less
Keywords
phase 1 study
clinical trial
treatment efficacy
solid tumour